DTC and DTCFF Related Headlines
Go Back- Defence Therapeutics Announces Convertible Debenture Interest Payment
- Defence Therapeutics Wins Best Poster Award and Takes Center Stage at World ADC San Diego 2026, a Key Recognition in the Field Highlighting the Potential of Its Accum Platform
- Defence Therapeutics to Take the Stage at World ADC San Diego to Discuss the Next Frontier in Antibody-Drug Conjugates
- Defence Therapeutics names ex-Xenon CFO Sherry Aulin to its board
- Defence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors
- Defence Therapeutics Provides Corporate Update as Company Executes on Strategic Priorities
- Defence Therapeutics CEO outlines three strategic priorities in letter
- Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders
- Defence Therapeutics Provides Updates on Sharing Agreement
DTC and DTCFF Related Press Releases
Go Back- Defence Therapeutics Announces Convertible Debenture Interest Payment
- Defence Therapeutics Wins Best Poster Award and Takes Center Stage at World ADC San Diego 2026, a Key Recognition in the Field Highlighting the Potential of Its Accum Platform
- Defence Therapeutics to Take the Stage at World ADC San Diego to Discuss the Next Frontier in Antibody-Drug Conjugates
- Defence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors
- Defence Therapeutics Provides Corporate Update as Company Executes on Strategic Priorities
- Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders
- Defence Therapeutics Provides Updates on Sharing Agreement
